What is the standard reversal agent for dexmedetomidine (an alpha-2 agonist) in veterinary practice?

• A. Naloxone
• B. Atipamezole
• C. Flumazenil
• D. Yohimbine

Answer: (B)

Dexmedetomidine is an alpha-2 adrenergic agonist, so reversing its effects means blocking those same receptors with an alpha-2 antagonist. Atipamezole is a selective alpha-2 antagonist designed for veterinary use; it tightly binds to alpha-2 receptors and quickly counters the sedative, analgesic, and cardiovascular effects of dexmedetomidine, leading to a rapid and predictable recovery with fewer side effects. That targeted action is why it’s the standard reversal in practice.

Naloxone and flumazenil reverse opioids and benzodiazepines, respectively, not alpha-2 agonists, so they won’t effectively reverse dexmedetomidine’s effects. Yohimbine is also an alpha-2 antagonist and can reverse some alpha-2 agonists (notably xylazine), but it’s less selective and yields more variable results and adverse effects, making it a less reliable choice for reversing dexmedetomidine in routine veterinary care.